{"accession":"0001549595-26-000049","article_url":"https://aiswingx.com/p/nrix-2026q3","attribution":"aiSwingX \u2014 https://aiswingx.com/n/0001549595-26-000049/NetCashProvidedByUsedInOperatingActivities","change":3.461799342630469,"cik":1549595,"company":"NURIX THERAPEUTICS, INC.","concept":{"label":"Operating cash flow","label_en":"Operating cash flow","label_ko":"\uc601\uc5c5\ud65c\ub3d9 \ud604\uae08\ud750\ub984","period_type":"duration","xbrl_tag":"NetCashProvidedByUsedInOperatingActivities"},"filed_at":"2026-10-13","filing_index_url":"https://www.sec.gov/Archives/edgar/data/1549595/000154959526000049/0001549595-26-000049-index.htm","filing_url":"https://aiswingx.com/f/0001549595-26-000049","form":"10-Q","id":"0001549595-26-000049/NetCashProvidedByUsedInOperatingActivities","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-08-31","period_start":"2025-12-01","source_url":"https://www.sec.gov/Archives/edgar/data/1549595/000154959526000049/nrix-20260831.htm#f-335","unit":"USD","value":447144000.0,"xbrl_fact_id":"f-335"},{"comparative":true,"instant":false,"period_end":"2025-08-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1549595/000154959526000049/nrix-20260831.htm#f-336","unit":"USD","value":-181633000.0,"xbrl_fact_id":"f-336"}],"statement":"NURIX THERAPEUTICS, INC. (NRIX) reported Operating cash flow of USD 447,144,000 for the period from 2025-12-01 to 2026-08-31 in its 10-Q (accession 0001549595-26-000049, filed 2026-10-13).","ticker":"NRIX","url":"https://aiswingx.com/n/0001549595-26-000049/NetCashProvidedByUsedInOperatingActivities","verify_url":"https://www.sec.gov/Archives/edgar/data/1549595/000154959526000049/nrix-20260831.htm#f-335"}